Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.07), versus ($0.03) reported last year. Revenue for the quarter came in at $8.1 million, versus $9.25 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.